A detailed history of Carson Advisory Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Carson Advisory Inc. holds 2,757 shares of ILMN stock, worth $377,681. This represents 0.24% of its overall portfolio holdings.

Number of Shares
2,757
Previous 2,655 3.84%
Holding current value
$377,681
Previous $277,000 29.6%
% of portfolio
0.24%
Previous 0.2%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$105.28 - $135.9 $10,738 - $13,861
102 Added 3.84%
2,757 $359,000
Q2 2024

Aug 07, 2024

BUY
$101.05 - $133.57 $101,050 - $133,570
1,000 Added 60.42%
2,655 $277,000
Q1 2024

May 03, 2024

BUY
$127.73 - $147.2 $25,546 - $29,439
200 Added 13.75%
1,655 $227,000
Q4 2023

Feb 06, 2024

SELL
$92.79 - $142.53 $13,918 - $21,379
-150 Reduced 9.35%
1,455 $202,000
Q2 2023

Jul 28, 2023

BUY
$183.43 - $232.67 $294,405 - $373,435
1,605 New
1,605 $300,000
Q3 2022

Nov 07, 2022

BUY
$177.23 - $227.44 $284,454 - $365,041
1,605 New
1,605 $306,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Carson Advisory Inc. Portfolio

Follow Carson Advisory Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carson Advisory Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carson Advisory Inc. with notifications on news.